AI assistant
Sending…
ImageneBio, Inc. — Director's Dealing 2021
Apr 16, 2021
34275_dirs_2021-04-15_f3c67cd6-97e2-47e3-9483-f69c252cc2d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Ikena Oncology, Inc. (IKNA)
CIK: 0001835579
Period of Report: 2021-04-15
Reporting Person: Koehler Maria (Director)
More from ImageneBio, Inc.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 12